Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Figer

Showing results (31-40 of 46) with videos related to

Pageof 5
Sort By:
British Journal of Cancer|June 16, 2011
XELOX vs FOLFOX-4 as first-line therapy for metastatic colorectal cancer: NO16966 updated resultsJ Cassidy, S Clarke, E Díaz-Rubio, et al.
Gynecologic Oncology|November 5, 1997
Estrogen and progesterone receptor expression in postmenopausal tamoxifen-exposed endometrial pathologiesI Cohen, Y Beyth, M M Altaras, et al.
European Journal of Human Genetics : EJHG|August 10, 1999
Common origin of the I1307K APC polymorphism in Ashkenazi and non-Ashkenazi JewsY Patael, A Figer, R Gershoni-Baruch, et al.
Cancer|November 1, 1987
Familial colon cancer in the Tel-Aviv area and the influence of ethnic originP Rozen, H T Lynch, A Figer, et al.
Genetic Testing|September 12, 2001
The I1307K APC polymorphism: prevalence in non-Ashkenazi Jews and evidence for a founder effectR Shtoyerman-Chen, E Friedman, A Figer, et al.
International Journal of Gynecological Pathology : Official Journal of the International Society of Gynecological Pathologists|April 1, 1996
Time-dependent effect of tamoxifen therapy on endometrial pathology in asymptomatic postmenopausal breast cancer patientsI Cohen, M M Altaras, J Shapira, et al.
Genetic Testing|January 6, 2001
Genetic analyses of male breast cancer in IsraelR S Sverdlov, I Barshack, R B Bar Sade, et al.
British Journal of Cancer|November 27, 2001
Phenotypic characteristics of colo-rectal cancer in I1307K APC germline mutation carriers compared with sporadic casesA Figer, R Shtoyerman-Chen, A Tamir, et al.
Breast Cancer Research and Treatment|June 16, 1999
Dose-dependent effect of tamoxifen therapy on endometrial pathologies in postmenopausal breast cancer patientsI Cohen, E Perel, R Tepper, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 21, 2009
Efficacy of FOLFIRI-3 (irinotecan D1,D3 combined with LV5-FU) or other irinotecan-based regimens in oxaliplatin-pretreated metastatic colorectal cancer in the GERCOR OPTIMOX1 studyF-C Bidard, C Tournigand, T André, et al.
Pageof 5

Showing results (31-40 of 46) with videos related to

Sort By:
Pageof 5
British Journal of Cancer|June 16, 2011
XELOX vs FOLFOX-4 as first-line therapy for metastatic colorectal cancer: NO16966 updated resultsJ Cassidy, S Clarke, E Díaz-Rubio, et al.
Gynecologic Oncology|November 5, 1997
Estrogen and progesterone receptor expression in postmenopausal tamoxifen-exposed endometrial pathologiesI Cohen, Y Beyth, M M Altaras, et al.
European Journal of Human Genetics : EJHG|August 10, 1999
Common origin of the I1307K APC polymorphism in Ashkenazi and non-Ashkenazi JewsY Patael, A Figer, R Gershoni-Baruch, et al.
Cancer|November 1, 1987
Familial colon cancer in the Tel-Aviv area and the influence of ethnic originP Rozen, H T Lynch, A Figer, et al.
Genetic Testing|September 12, 2001
The I1307K APC polymorphism: prevalence in non-Ashkenazi Jews and evidence for a founder effectR Shtoyerman-Chen, E Friedman, A Figer, et al.
International Journal of Gynecological Pathology : Official Journal of the International Society of Gynecological Pathologists|April 1, 1996
Time-dependent effect of tamoxifen therapy on endometrial pathology in asymptomatic postmenopausal breast cancer patientsI Cohen, M M Altaras, J Shapira, et al.
Genetic Testing|January 6, 2001
Genetic analyses of male breast cancer in IsraelR S Sverdlov, I Barshack, R B Bar Sade, et al.
British Journal of Cancer|November 27, 2001
Phenotypic characteristics of colo-rectal cancer in I1307K APC germline mutation carriers compared with sporadic casesA Figer, R Shtoyerman-Chen, A Tamir, et al.
Breast Cancer Research and Treatment|June 16, 1999
Dose-dependent effect of tamoxifen therapy on endometrial pathologies in postmenopausal breast cancer patientsI Cohen, E Perel, R Tepper, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 21, 2009
Efficacy of FOLFIRI-3 (irinotecan D1,D3 combined with LV5-FU) or other irinotecan-based regimens in oxaliplatin-pretreated metastatic colorectal cancer in the GERCOR OPTIMOX1 studyF-C Bidard, C Tournigand, T André, et al.
Pageof 5